Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Gurus
Other
BAKER BROS. ADVISORS LP (Data extracted from 13F, 13D, 13G and Form 4)

Subscribe For Premium Access

BAKER BROS. ADVISORS LP

AUM: $21.98 B

13-F Portfolio Value: $19.96 B

Last 13-F Filed: Q2 2026

Concentration in top 10: 72.83%

Stock	Company	% Portfolio	Shares Held	Market Value	Change in Shares	% Change	Quarter End Price	Source
ABVX	Abivax S.A.				-875,796	Exited		13F
SYRE	Spyre Therapeutics, Inc.				-1,000,000	Exited		13F
ARGX	argenx SE				-25,174	Exited		13F
CELC	Celcuity Inc.				-30,750,000	Exited		13F
CNTA	Centessa Pharmaceuticals plc				-670,751	Exited		13F
CMPS	COMPASS Pathways plc				-2,344,720	Exited		13F
CTNM	Contineum Therapeutics, Inc.				-1,420,838	Exited		13F
IMCR	Immunocore Holdings plc				-734,397	Exited		13F
PHVS	Pharvaris N.V.				-375,000	Exited		13F